IMpassion031: Results from a phase III study of neoadjuvant (neoadj) atezolizumab plus chemo in early triple-negative breast cancer (TNBC)-MedSci.cn

IMpassion031: Results from a phase III study of neoadjuvant (neoadj) atezolizumab plus chemo in early triple-negative breast cancer (TNBC)

Saji, S; Mittendorf, E; Harbeck, N; Zhang, H; Barrios, CH; Hegg, R; Koehler, A; Sohn, J; Iwata, H; Telli, ML; Ferrario, C; Punie, K; Llorca, FP; Patel, S; Duc, AN; Hermoso, ML; Maiya, V; Molinero, L; Chui, S; Jung, KH

ANNALS OF ONCOLOGY, 2020; 31 (): S1243

科室
- - 订阅+
  - 更多科室
工具
服务

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

IMpassion031: Results from a phase III study of neoadjuvant (neoadj) atezolizumab plus chemo in early triple-negative breast cancer (TNBC)

科室

工具

服务